Literature DB >> 16245278

90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression.

Elisabeth L Bair1, Raymond B Nagle, Tricia A Ulmer, Suzanne Laferté, G Tim Bowden.   

Abstract

BACKGROUND: 90K/Mac-2 binding protein is a cell adhesive protein whose level of expression has been correlated with metastatic potential in many different tumor types. The purpose of this investigation was to examine 90K expression in prostate cancer and to determine a possible role for 90K in cancer progression.
METHODS: 90K expression in prostate cell lines and tissue samples was evaluated by immunohistochemistry. Expression in cell lines was also evaluated by Western blot analysis and real-time RT-PCR. Induction of promatrilysin by 90K was evaluated by ELISA.
RESULTS: Some of the human prostate cell lines studied expressed 90K. 90K was over-expressed in 38.8% of prostate cancer tumor samples, 7.14% of PIN lesions, and 18.6% of normal tissue. 90K was also shown to induce promatrilysin expression in the prostate cell line, LNCaP.
CONCLUSIONS: These data demonstrate that 90K is over-expressed in a large fraction of malignant tumors. The fact that 90K can induce expression of promatrilysin indicates a possible role for 90K in cancer progression and metastasis. This suggests that 90K over-expression may be a useful marker for examining prostate cancer progression. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16245278     DOI: 10.1002/pros.20343

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

1.  Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen.

Authors:  Ashley S Block; Sarika Saraswati; Cheryl F Lichti; Maha Mahadevan; Alan B Diekman
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

2.  A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.

Authors:  Ayaka M Silverman; Rie Nakata; Hiroyuki Shimada; Richard Sposto; Yves A DeClerck
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

Review 3.  Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Valentina Gallo; Alyexandra Arienzo; Stefano Iacobelli; Valentina Iacobelli; Giovanni Antonini
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

4.  Simplified purification procedure of laminin-332 and laminin-511 from human cell lines.

Authors:  Isis C Sroka; Man Ling Chen; Anne E Cress
Journal:  Biochem Biophys Res Commun       Date:  2008-08-17       Impact factor: 3.575

5.  Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach.

Authors:  Yanfei Wang; Xiaoping Ao; Huy Vuong; Meghana Konanur; Fred R Miller; Steve Goodison; David M Lubman
Journal:  J Proteome Res       Date:  2008-08-27       Impact factor: 4.466

6.  Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.

Authors:  Flaubert Mbeunkui; Brandon J Metge; Lalita A Shevde; Lewis K Pannell
Journal:  J Proteome Res       Date:  2007-07-04       Impact factor: 4.466

7.  Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin-p120-Catenin Complex.

Authors:  So-Yeon Park; Somy Yoon; Eun Gene Sun; Rui Zhou; Jeong A Bae; Young-Woo Seo; Jung-Il Chae; Man-Jeong Paik; Hyung-Ho Ha; Hangun Kim; Kyung Keun Kim
Journal:  Int J Mol Sci       Date:  2017-12-02       Impact factor: 5.923

8.  Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.

Authors:  Emina Emilia Torlakovic; Vicki Keeler; Chang Wang; Hyun J Lim; Leslie Ann Lining; Suzanne Laferté
Journal:  BMC Cancer       Date:  2009-07-24       Impact factor: 4.430

9.  Expression and significance of 90K/Mac-2BP in prostate cancer.

Authors:  Jianxin Hu; Jian He; Youlin Kuang; Zhenxing Wang; Zhaolin Sun; Hengcheng Zhu; Xiuheng Liu
Journal:  Exp Ther Med       Date:  2012-10-25       Impact factor: 2.447

10.  90K Glycoprotein Promotes Degradation of Mutant β-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus.

Authors:  So-Yeon Park; Somy Yoon; Hangun Kim; Kyung Keun Kim
Journal:  Neoplasia       Date:  2016-09-23       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.